CDC Updates Vaccine Price Lists
The U.S. Centers for Disease Control and Prevention (CDC) reviewed/updated July 1 the CDC Vaccine Price Lists, which provide current contract and private sector vaccine prices. Contract prices are for CDC vaccine contracts that are established for the purchase of vaccines by immunization programs receiving CDC immunization grant funds (i.e., state health departments, certain large city immunization projects, and certain current and former U.S. territories).
As of May 14, the CDC vaccine price list also shows the National Drug Code (NDC) code and contract number for each vaccine.
The CDC Vaccine Price Lists are available on the CDC website.
“Merck’s adult and dialysis formulations of their hepatitis B vaccine (Recombivax HB®) currently are not available. The adult formulation will not be available during the remainder of 2010; the dialysis formulation is expected to become available in Q3 of 2010. Production and supply of GSK’s adult hepatitis B vaccine (Adult Engerix-B®) and Adult hepatitis A/hepatitis B combination vaccine (Twinrix®) currently are sufficient to meet demand for routine adult usage of this vaccine as well as CDC’s ongoing High Risk Adult Hepatitis B Initiative.”
The adult formulation of hepatitis A vaccine (VAQTA®) from Merck also will not be available in 2010. “GSK is currently out of stock on both presentations (syringe and vial) of its adult hepatitis A vaccine (though some distributors may still have product available) but anticipates that sufficient supply of at least one presentation will be available to meet demand for routine adult usage of this product by the end of June. In addition, GSK’s adult hepatitis A/ hepatitis B combination vaccine (Twinrix®) currently is available as an alternative product.”
Health care professionals may also be interested in a self-study education program called “Adult Immunization 2010” now available courtesy of the CDC.